COVID 19

COVID-19 response service

Since the onset of the COVID-19 pandemic, our end-to-end solutions have assisted in the control and containment of COVID-19 outbreaks.
‍
AID Genomics Jerusalem Laboratory is a state-of-the-art facility established over good manufacturing practice (GMP) level infrastructure that can deliver tens of thousands of tests per day across Israel, which has a population of 9 million.
‍
We have supplied Israeli laboratories with reagents, consumables, and software solutions that were used to perform millions of COVID-19 diagnostics determinations on a nationwide level. We also assisted in the establishment of 7 additional independent, IMOH accredited laboratories across Israel. Outside Israel, more fully functional, accredited COVID-19 lab as a turn-key solution are being established in several international locations, such as Kazakhstan.
‍
We can deliver tests to individuals or groups, anywhere and anytime, according to demand. Our COVID-19 laboratory operates 24/7, serving dozens of AID Genomics-operated sampling locations, spread across Israel. In addition, the lab is serving incoming passengers arriving at TLV Airport and also samples sent to the MOH\MOD from across the country.
‍
Our diagnostic tests are performed by professional health care personnel accredited by Israel’s Ministry of Health. A negative test result grants the individual a COVID-19 Free certificate, which can be used as a Fit-to-Fly document for travel and/or attending public events.

Antigen test

TestAID Genomics offers a COVID-19 Rapid Antigen Test, which enables rapid detection of viral Nucleocapsid protein directly from nasal, nasopharyngeal, or oropharyngeal swab samples.Testing can be accomplished easily,and simply within 15 minutes. Interpretation of results can be performed visually or by AID Genomics’ proprietary mobile application.The test is approved for use by professional healthcare personnel, as well as for at-home use.The tests are accredited by the EU (CE-IVD), the German MOH (BfARM), and the UK (MHRA).AID Genomics is also offering COVID-19 rapid antigen testing services to be performed by our dedicated professionals atlarge events (e.g., sports events, concerts, etc.).

RT-PCR Testing

RT-PCR testing is considered the “gold standard” in COVID-19 detection. This test detects the presence of COVID-19 viral RNA that is specific to the SARS-CoV2 virus and can detect the virus within days following infection, even in those who display no symptoms. Our proprietary testing methods use automated workflows that enable the successful delivery of >98% of our tests within up to six hours.

We provide both RT-PCR testing services (B2G, B2B, B2C), as well as reagents and consumables for third-party laboratories (B2G, B2B).

Our fully staffedCOVID-19 RT-PCR facilities process up to 70,000 tests each day.The automated systems mean that batch quality is maintained at every level and reports on test results can be easily and quickly generated.Our systems also allow us to run real-time insight into equipment performance and identify anomaliesacross all of our operators and sites.

Enabling Populations To Move Safely

Swab-sampling can ensure testing is in place, enabling people to ‘return to normal’ and resume desired routine activities. We provide testing solutions for:

Cruises

- Produce a report before a ship dock to enable passenger testing, particularly for those showing symptoms
-Regular testing of cruise ship personnel
-Spot testing of passengers

Stores

- Regular testing of staff
- Use of facial recognition iPad for identification purposes when taking swab samples

Hotels

- Regular testing of hotel staff
-Use of facial recognition iPad to identify staff and monitor symptoms
-Testing of hotel guests upon check-in/check-out

Airports

- Implement safety measures and offer swab testing
- Regular testing of airport staff
- Facial recognition iPad to identify staff and monitor symptoms
- Testing of people travelling on check-in/check-out

Hospitals

- Symptom reporting for both staff and patients
- Hotline number provided for symptom reporting
- Mobile unit testing is dispatched to those displaying symptoms so that they can receive immediate onsite testing
- Use of facial recognition iPad to identify staff members and monitor their symptoms

Pathogenic Microorganism Sequencing (PMSeq)

As a reliable supplier of extraction kits for a range of pathogens, AIDG has the readiness and preparedness for a possible next pandemic.

Detect all microorganisms in a clinical sample simply and easily
Detect known as well as new and novel microorganisms
Automated bioinformatic pipelines simplify analysis and result interpretation

COVID-19 response service

COVID-19 RESPONSE

Antigen test

RT-PCR Testing

Mobile testing